SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 42 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $800 | -100.0% | 428,000 | -84.5% | 0.00% | -100.0% |
| Q3 2022 | $4,638,000 | +15.1% | 2,761,000 | -13.4% | 0.01% | +150.0% |
| Q2 2022 | $4,028,000 | -9.2% | 3,187,000 | -5.6% | 0.00% | -33.3% |
| Q1 2022 | $4,434,000 | -59.1% | 3,376,000 | -54.9% | 0.00% | +50.0% |
| Q4 2021 | $10,838,000 | +173.7% | 7,480,000 | +181.3% | 0.00% | 0.0% |
| Q3 2021 | $3,960,000 | +10.6% | 2,659,000 | -1.2% | 0.00% | 0.0% |
| Q2 2021 | $3,579,000 | -23.5% | 2,691,000 | -24.8% | 0.00% | -33.3% |
| Q1 2021 | $4,677,000 | +426.1% | 3,580,000 | +517.2% | 0.00% | +200.0% |
| Q1 2020 | $889,000 | -17.0% | 580,000 | +5.3% | 0.00% | 0.0% |
| Q4 2019 | $1,071,000 | +157.5% | 551,000 | +74.9% | 0.00% | – |
| Q3 2019 | $416,000 | +462.2% | 315,000 | +826.5% | 0.00% | – |
| Q2 2019 | $74,000 | -79.8% | 34,000 | -83.3% | 0.00% | – |
| Q1 2019 | $366,000 | – | 203,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DLD Asset Management, LP | 10,370,000 | $18,432,675 | 1.98% |
| Worth Venture Partners, LLC | 1,431,000 | $2,536,677 | 1.50% |
| CSS LLC/IL | 8,197,000 | $14,535,142 | 0.95% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,198,000 | $9,252,647 | 0.20% |
| Warberg Asset Management LLC | 517,000 | $911,580 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 3,889,000 | $6,893,877 | 0.16% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,000,000 | $1,765,625 | 0.05% |
| Point72 Asset Management, L.P. | 9,007,000 | $15,925,009 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,082,000 | $8,984,976 | 0.04% |
| D. E. Shaw & Co., Inc. | 11,089,000 | $19,645,113 | 0.02% |